Made in Israel: A living implant aims to restore movement after paralysis
JNSBuilt from a patient’s own cells, the technology is advancing toward its first human trial at Sheba Medical Center in 2027, pending regulatory approval.
JNSJNSJNSBuilt from a patient’s own cells, the technology is advancing toward its first human trial at Sheba Medical Center in 2027, pending regulatory approval.